LGVN - Longeveron stock rallies 19% on Alzheimer's drug update
2024-07-17 12:15:33 ET
More on Longeveron
- Longeveron Inc. (LGVN) Q1 2024 Earnings Call Transcript
- Longeveron surges on key FDA designation for Alzheimer’s drug
- Longeveron announces exercise of warrants for $4.4M gross proceeds
- Seeking Alpha’s Quant Rating on Longeveron
- Historical earnings data for Longeveron